GW Pharmaceuticals plc gibt Finanzergebnisse und operativen Fortschritt für das am 31. Dezember 2018 endende Quartal bekannt

26.02.2019 GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the

Aurora Cannabis expandiert nach Portugal und stärkt die Marktführerschaft in Europa

26. Februar 2019 Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries   EDMONTON, Feb. 26, 2019 /CNW/ – Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has agreed to terms to acquire